nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Promazine—Tamoxifen—breast cancer	0.26	1	CrCrCtD
Propericiazine—Trifluoperazine—S100A4—breast cancer	0.00291	0.213	CrCbGaD
Propericiazine—Ethopropazine—BCHE—breast cancer	0.000699	0.0512	CrCbGaD
Propericiazine—Clomipramine—GSTP1—breast cancer	0.000587	0.043	CrCbGaD
Propericiazine—Triflupromazine—BCHE—breast cancer	0.000572	0.042	CrCbGaD
Propericiazine—Agranulocytosis—Docetaxel—breast cancer	0.000487	0.000772	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—breast cancer	0.000486	0.000771	CcSEcCtD
Propericiazine—Confusional state—Mitoxantrone—breast cancer	0.000485	0.00077	CcSEcCtD
Propericiazine—Confusional state—Irinotecan—breast cancer	0.000485	0.00077	CcSEcCtD
Propericiazine—Oedema—Mitoxantrone—breast cancer	0.000481	0.000763	CcSEcCtD
Propericiazine—Oedema—Irinotecan—breast cancer	0.000481	0.000763	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—breast cancer	0.000481	0.000763	CcSEcCtD
Propericiazine—Diarrhoea—Vinblastine—breast cancer	0.000481	0.000762	CcSEcCtD
Propericiazine—Hypersensitivity—Goserelin—breast cancer	0.00048	0.000761	CcSEcCtD
Propericiazine—Infection—Irinotecan—breast cancer	0.000478	0.000758	CcSEcCtD
Propericiazine—Infection—Mitoxantrone—breast cancer	0.000478	0.000758	CcSEcCtD
Propericiazine—Constipation—Thiotepa—breast cancer	0.000477	0.000756	CcSEcCtD
Propericiazine—Agranulocytosis—Capecitabine—breast cancer	0.000472	0.000747	CcSEcCtD
Propericiazine—Tachycardia—Mitoxantrone—breast cancer	0.00047	0.000745	CcSEcCtD
Propericiazine—Oedema—Gemcitabine—breast cancer	0.000469	0.000743	CcSEcCtD
Propericiazine—Diarrhoea—Tamoxifen—breast cancer	0.000467	0.00074	CcSEcCtD
Propericiazine—Infection—Gemcitabine—breast cancer	0.000466	0.000739	CcSEcCtD
Propericiazine—Hyperhidrosis—Irinotecan—breast cancer	0.000465	0.000738	CcSEcCtD
Propericiazine—Hyperhidrosis—Mitoxantrone—breast cancer	0.000465	0.000738	CcSEcCtD
Propericiazine—Confusional state—Fluorouracil—breast cancer	0.000465	0.000737	CcSEcCtD
Propericiazine—Body temperature increased—Vinorelbine—breast cancer	0.000462	0.000732	CcSEcCtD
Propericiazine—Oedema—Fluorouracil—breast cancer	0.000461	0.000731	CcSEcCtD
Propericiazine—Infection—Fluorouracil—breast cancer	0.000458	0.000726	CcSEcCtD
Propericiazine—Diarrhoea—Melphalan—breast cancer	0.000457	0.000725	CcSEcCtD
Propericiazine—Nausea—Chlorambucil—breast cancer	0.000455	0.000722	CcSEcCtD
Propericiazine—Vision blurred—Paclitaxel—breast cancer	0.000453	0.000719	CcSEcCtD
Propericiazine—Hyperhidrosis—Gemcitabine—breast cancer	0.000453	0.000719	CcSEcCtD
Propericiazine—Tremor—Paclitaxel—breast cancer	0.000451	0.000715	CcSEcCtD
Propericiazine—Tachycardia—Fluorouracil—breast cancer	0.00045	0.000713	CcSEcCtD
Propericiazine—Hypotension—Mitoxantrone—breast cancer	0.00045	0.000713	CcSEcCtD
Propericiazine—Hypotension—Irinotecan—breast cancer	0.00045	0.000713	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—breast cancer	0.00045	0.000713	CcSEcCtD
Propericiazine—Vomiting—Vinblastine—breast cancer	0.000447	0.000708	CcSEcCtD
Propericiazine—Diarrhoea—Goserelin—breast cancer	0.000446	0.000707	CcSEcCtD
Propericiazine—Agitation—Paclitaxel—breast cancer	0.000442	0.000701	CcSEcCtD
Propericiazine—Body temperature increased—Thiotepa—breast cancer	0.000441	0.000699	CcSEcCtD
Propericiazine—Angioedema—Paclitaxel—breast cancer	0.00044	0.000697	CcSEcCtD
Propericiazine—Hypotension—Gemcitabine—breast cancer	0.000438	0.000695	CcSEcCtD
Propericiazine—Insomnia—Irinotecan—breast cancer	0.000435	0.00069	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—breast cancer	0.000435	0.000689	CcSEcCtD
Propericiazine—Vomiting—Tamoxifen—breast cancer	0.000434	0.000688	CcSEcCtD
Propericiazine—Hypotension—Fluorouracil—breast cancer	0.000431	0.000683	CcSEcCtD
Propericiazine—Rash—Tamoxifen—breast cancer	0.00043	0.000682	CcSEcCtD
Propericiazine—Hypersensitivity—Vinorelbine—breast cancer	0.00043	0.000682	CcSEcCtD
Propericiazine—Dermatitis—Tamoxifen—breast cancer	0.00043	0.000681	CcSEcCtD
Propericiazine—Dyspnoea—Irinotecan—breast cancer	0.000429	0.00068	CcSEcCtD
Propericiazine—Dyspnoea—Mitoxantrone—breast cancer	0.000429	0.00068	CcSEcCtD
Propericiazine—Somnolence—Irinotecan—breast cancer	0.000428	0.000679	CcSEcCtD
Propericiazine—Somnolence—Mitoxantrone—breast cancer	0.000428	0.000679	CcSEcCtD
Propericiazine—Vomiting—Melphalan—breast cancer	0.000425	0.000673	CcSEcCtD
Propericiazine—Insomnia—Gemcitabine—breast cancer	0.000424	0.000672	CcSEcCtD
Propericiazine—Asthma—Methotrexate—breast cancer	0.000422	0.000669	CcSEcCtD
Propericiazine—Rash—Melphalan—breast cancer	0.000421	0.000668	CcSEcCtD
Propericiazine—Cardiac disorder—Capecitabine—breast cancer	0.000421	0.000667	CcSEcCtD
Propericiazine—Dermatitis—Melphalan—breast cancer	0.000421	0.000667	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—breast cancer	0.000419	0.000663	CcSEcCtD
Propericiazine—Dyspnoea—Gemcitabine—breast cancer	0.000418	0.000663	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—breast cancer	0.000418	0.000662	CcSEcCtD
Propericiazine—Nausea—Vinblastine—breast cancer	0.000417	0.000661	CcSEcCtD
Propericiazine—Insomnia—Fluorouracil—breast cancer	0.000417	0.000661	CcSEcCtD
Propericiazine—Somnolence—Gemcitabine—breast cancer	0.000417	0.000661	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—breast cancer	0.000416	0.000659	CcSEcCtD
Propericiazine—Vomiting—Goserelin—breast cancer	0.000414	0.000657	CcSEcCtD
Propericiazine—Constipation—Mitoxantrone—breast cancer	0.000412	0.000653	CcSEcCtD
Propericiazine—Constipation—Irinotecan—breast cancer	0.000412	0.000653	CcSEcCtD
Propericiazine—Dyspnoea—Fluorouracil—breast cancer	0.000411	0.000652	CcSEcCtD
Propericiazine—Rash—Goserelin—breast cancer	0.000411	0.000651	CcSEcCtD
Propericiazine—Hypersensitivity—Thiotepa—breast cancer	0.000411	0.000651	CcSEcCtD
Propericiazine—Dermatitis—Goserelin—breast cancer	0.000411	0.000651	CcSEcCtD
Propericiazine—Somnolence—Fluorouracil—breast cancer	0.00041	0.00065	CcSEcCtD
Propericiazine—Nausea—Tamoxifen—breast cancer	0.000405	0.000643	CcSEcCtD
Propericiazine—Arrhythmia—Capecitabine—breast cancer	0.000405	0.000642	CcSEcCtD
Propericiazine—Constipation—Gemcitabine—breast cancer	0.000401	0.000636	CcSEcCtD
Propericiazine—Dry mouth—Paclitaxel—breast cancer	0.000401	0.000635	CcSEcCtD
Propericiazine—Diarrhoea—Vinorelbine—breast cancer	0.000399	0.000633	CcSEcCtD
Propericiazine—Nausea—Melphalan—breast cancer	0.000397	0.000629	CcSEcCtD
Propericiazine—Confusional state—Paclitaxel—breast cancer	0.000396	0.000628	CcSEcCtD
Propericiazine—Asthma—Epirubicin—breast cancer	0.000395	0.000626	CcSEcCtD
Propericiazine—Mequitazine—CYP2D6—breast cancer	0.000393	0.0288	CrCbGaD
Propericiazine—Oedema—Paclitaxel—breast cancer	0.000393	0.000622	CcSEcCtD
Propericiazine—Alimemazine—CYP3A4—breast cancer	0.000391	0.0287	CrCbGaD
Propericiazine—Eosinophilia—Epirubicin—breast cancer	0.000391	0.00062	CcSEcCtD
Propericiazine—Infection—Paclitaxel—breast cancer	0.00039	0.000618	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—breast cancer	0.000389	0.000616	CcSEcCtD
Propericiazine—Domperidone—CYP2D6—breast cancer	0.000388	0.0284	CrCbGaD
Propericiazine—Nausea—Goserelin—breast cancer	0.000387	0.000614	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—breast cancer	0.000385	0.00061	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—breast cancer	0.000385	0.00061	CcSEcCtD
Propericiazine—Tachycardia—Paclitaxel—breast cancer	0.000383	0.000607	CcSEcCtD
Propericiazine—Diarrhoea—Thiotepa—breast cancer	0.000381	0.000605	CcSEcCtD
Propericiazine—Body temperature increased—Mitoxantrone—breast cancer	0.000381	0.000603	CcSEcCtD
Propericiazine—Body temperature increased—Irinotecan—breast cancer	0.000381	0.000603	CcSEcCtD
Propericiazine—Hyperhidrosis—Paclitaxel—breast cancer	0.00038	0.000602	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—breast cancer	0.000378	0.0006	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—breast cancer	0.000376	0.000596	CcSEcCtD
Propericiazine—Vision blurred—Capecitabine—breast cancer	0.000372	0.00059	CcSEcCtD
Propericiazine—Vomiting—Vinorelbine—breast cancer	0.000371	0.000588	CcSEcCtD
Propericiazine—Body temperature increased—Gemcitabine—breast cancer	0.000371	0.000588	CcSEcCtD
Propericiazine—Tremor—Capecitabine—breast cancer	0.00037	0.000586	CcSEcCtD
Propericiazine—Rash—Vinorelbine—breast cancer	0.000368	0.000583	CcSEcCtD
Propericiazine—Dermatitis—Vinorelbine—breast cancer	0.000368	0.000583	CcSEcCtD
Propericiazine—Hypotension—Paclitaxel—breast cancer	0.000367	0.000582	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—breast cancer	0.000365	0.000579	CcSEcCtD
Propericiazine—Body temperature increased—Fluorouracil—breast cancer	0.000365	0.000578	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—breast cancer	0.000362	0.000573	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—breast cancer	0.00036	0.000571	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—breast cancer	0.000359	0.00057	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—breast cancer	0.000356	0.000564	CcSEcCtD
Propericiazine—Insomnia—Paclitaxel—breast cancer	0.000355	0.000563	CcSEcCtD
Propericiazine—Hypersensitivity—Irinotecan—breast cancer	0.000355	0.000562	CcSEcCtD
Propericiazine—Hypersensitivity—Mitoxantrone—breast cancer	0.000355	0.000562	CcSEcCtD
Propericiazine—Vomiting—Thiotepa—breast cancer	0.000354	0.000562	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—breast cancer	0.000354	0.000561	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—breast cancer	0.000352	0.000558	CcSEcCtD
Propericiazine—Rash—Thiotepa—breast cancer	0.000352	0.000557	CcSEcCtD
Propericiazine—Dermatitis—Thiotepa—breast cancer	0.000351	0.000557	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—breast cancer	0.000351	0.000556	CcSEcCtD
Propericiazine—Dyspnoea—Paclitaxel—breast cancer	0.00035	0.000555	CcSEcCtD
Propericiazine—Somnolence—Paclitaxel—breast cancer	0.000349	0.000553	CcSEcCtD
Propericiazine—Nausea—Vinorelbine—breast cancer	0.000347	0.00055	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—breast cancer	0.000343	0.000544	CcSEcCtD
Propericiazine—Hypersensitivity—Fluorouracil—breast cancer	0.00034	0.000539	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—breast cancer	0.00034	0.000538	CcSEcCtD
Propericiazine—Mequitazine—CYP3A4—breast cancer	0.000337	0.0247	CrCbGaD
Propericiazine—Constipation—Paclitaxel—breast cancer	0.000336	0.000532	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—breast cancer	0.000336	0.000532	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—breast cancer	0.000333	0.000529	CcSEcCtD
Propericiazine—Domperidone—CYP3A4—breast cancer	0.000333	0.0244	CrCbGaD
Propericiazine—Oedema—Docetaxel—breast cancer	0.000333	0.000528	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—breast cancer	0.000332	0.000527	CcSEcCtD
Propericiazine—Nausea—Thiotepa—breast cancer	0.000331	0.000525	CcSEcCtD
Propericiazine—Infection—Docetaxel—breast cancer	0.000331	0.000524	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—breast cancer	0.00033	0.000522	CcSEcCtD
Propericiazine—Diarrhoea—Mitoxantrone—breast cancer	0.000329	0.000522	CcSEcCtD
Propericiazine—Diarrhoea—Irinotecan—breast cancer	0.000329	0.000522	CcSEcCtD
Propericiazine—Dry mouth—Capecitabine—breast cancer	0.000329	0.000521	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—breast cancer	0.000328	0.000521	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—breast cancer	0.000328	0.000519	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—breast cancer	0.000326	0.000516	CcSEcCtD
Propericiazine—Confusional state—Capecitabine—breast cancer	0.000325	0.000515	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—breast cancer	0.000325	0.000515	CcSEcCtD
Propericiazine—Zuclopenthixol—CYP2D6—breast cancer	0.000324	0.0238	CrCbGaD
Propericiazine—Oedema—Capecitabine—breast cancer	0.000322	0.000511	CcSEcCtD
Propericiazine—Diarrhoea—Gemcitabine—breast cancer	0.000321	0.000509	CcSEcCtD
Propericiazine—Infection—Capecitabine—breast cancer	0.00032	0.000507	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—breast cancer	0.000317	0.000503	CcSEcCtD
Propericiazine—Diarrhoea—Fluorouracil—breast cancer	0.000316	0.0005	CcSEcCtD
Propericiazine—Tachycardia—Capecitabine—breast cancer	0.000315	0.000499	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—breast cancer	0.000313	0.000497	CcSEcCtD
Propericiazine—Hyperhidrosis—Capecitabine—breast cancer	0.000312	0.000494	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—breast cancer	0.000311	0.000493	CcSEcCtD
Propericiazine—Body temperature increased—Paclitaxel—breast cancer	0.00031	0.000492	CcSEcCtD
Propericiazine—Vomiting—Irinotecan—breast cancer	0.000306	0.000485	CcSEcCtD
Propericiazine—Vomiting—Mitoxantrone—breast cancer	0.000306	0.000485	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—breast cancer	0.000304	0.000482	CcSEcCtD
Propericiazine—Rash—Irinotecan—breast cancer	0.000304	0.000481	CcSEcCtD
Propericiazine—Rash—Mitoxantrone—breast cancer	0.000304	0.000481	CcSEcCtD
Propericiazine—Dermatitis—Irinotecan—breast cancer	0.000303	0.000481	CcSEcCtD
Propericiazine—Dermatitis—Mitoxantrone—breast cancer	0.000303	0.000481	CcSEcCtD
Propericiazine—Hypotension—Capecitabine—breast cancer	0.000301	0.000477	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—breast cancer	0.000301	0.000477	CcSEcCtD
Propericiazine—Vomiting—Gemcitabine—breast cancer	0.000298	0.000473	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—breast cancer	0.000297	0.00047	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—breast cancer	0.000296	0.000469	CcSEcCtD
Propericiazine—Rash—Gemcitabine—breast cancer	0.000296	0.000469	CcSEcCtD
Propericiazine—Dermatitis—Gemcitabine—breast cancer	0.000295	0.000468	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—breast cancer	0.000293	0.000465	CcSEcCtD
Propericiazine—Vomiting—Fluorouracil—breast cancer	0.000293	0.000465	CcSEcCtD
Propericiazine—Insomnia—Capecitabine—breast cancer	0.000291	0.000462	CcSEcCtD
Propericiazine—Rash—Fluorouracil—breast cancer	0.000291	0.000461	CcSEcCtD
Propericiazine—Dermatitis—Fluorouracil—breast cancer	0.00029	0.00046	CcSEcCtD
Propericiazine—Hypersensitivity—Paclitaxel—breast cancer	0.000289	0.000459	CcSEcCtD
Propericiazine—Dyspnoea—Capecitabine—breast cancer	0.000287	0.000455	CcSEcCtD
Propericiazine—Nausea—Irinotecan—breast cancer	0.000286	0.000453	CcSEcCtD
Propericiazine—Nausea—Mitoxantrone—breast cancer	0.000286	0.000453	CcSEcCtD
Propericiazine—Constipation—Docetaxel—breast cancer	0.000285	0.000451	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—breast cancer	0.000282	0.000447	CcSEcCtD
Propericiazine—Thiothixene—CYP2D6—breast cancer	0.000279	0.0205	CrCbGaD
Propericiazine—Pipotiazine—CYP2D6—breast cancer	0.000279	0.0205	CrCbGaD
Propericiazine—Nausea—Gemcitabine—breast cancer	0.000279	0.000442	CcSEcCtD
Propericiazine—Domperidone—ABCB1—breast cancer	0.000277	0.0203	CrCbGaD
Propericiazine—Vision blurred—Methotrexate—breast cancer	0.000277	0.000439	CcSEcCtD
Propericiazine—Chlorpromazine—BCHE—breast cancer	0.000276	0.0202	CrCbGaD
Propericiazine—Mesoridazine—CYP2D6—breast cancer	0.000276	0.0202	CrCbGaD
Propericiazine—Constipation—Capecitabine—breast cancer	0.000276	0.000437	CcSEcCtD
Propericiazine—Nausea—Fluorouracil—breast cancer	0.000274	0.000434	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—breast cancer	0.000271	0.00043	CcSEcCtD
Propericiazine—Diarrhoea—Paclitaxel—breast cancer	0.000269	0.000426	CcSEcCtD
Propericiazine—Prochlorperazine—CYP2D6—breast cancer	0.000267	0.0196	CrCbGaD
Propericiazine—Body temperature increased—Docetaxel—breast cancer	0.000263	0.000417	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—breast cancer	0.000261	0.000414	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—breast cancer	0.000259	0.000411	CcSEcCtD
Propericiazine—Body temperature increased—Capecitabine—breast cancer	0.000255	0.000404	CcSEcCtD
Propericiazine—Agitation—Epirubicin—breast cancer	0.000253	0.000401	CcSEcCtD
Propericiazine—Vomiting—Paclitaxel—breast cancer	0.00025	0.000396	CcSEcCtD
Propericiazine—Rash—Paclitaxel—breast cancer	0.000248	0.000392	CcSEcCtD
Propericiazine—Dermatitis—Paclitaxel—breast cancer	0.000247	0.000392	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—breast cancer	0.000245	0.000389	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—breast cancer	0.000242	0.000383	CcSEcCtD
Propericiazine—Fluphenazine—CYP2D6—breast cancer	0.000242	0.0177	CrCbGaD
Propericiazine—Vision blurred—Doxorubicin—breast cancer	0.00024	0.00038	CcSEcCtD
Propericiazine—Pipotiazine—CYP3A4—breast cancer	0.00024	0.0176	CrCbGaD
Propericiazine—Infection—Methotrexate—breast cancer	0.000238	0.000378	CcSEcCtD
Propericiazine—Hypersensitivity—Capecitabine—breast cancer	0.000237	0.000376	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—breast cancer	0.000234	0.000371	CcSEcCtD
Propericiazine—Nausea—Paclitaxel—breast cancer	0.000233	0.00037	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—breast cancer	0.000232	0.000368	CcSEcCtD
Propericiazine—Prochlorperazine—CYP3A4—breast cancer	0.000229	0.0168	CrCbGaD
Propericiazine—Dry mouth—Epirubicin—breast cancer	0.000229	0.000363	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—breast cancer	0.000228	0.000361	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—breast cancer	0.000226	0.000359	CcSEcCtD
Propericiazine—Oedema—Epirubicin—breast cancer	0.000225	0.000356	CcSEcCtD
Propericiazine—Triflupromazine—ABCB1—breast cancer	0.000224	0.0164	CrCbGaD
Propericiazine—Hypotension—Methotrexate—breast cancer	0.000224	0.000355	CcSEcCtD
Propericiazine—Infection—Epirubicin—breast cancer	0.000223	0.000354	CcSEcCtD
Propericiazine—Clomipramine—CYP2D6—breast cancer	0.000221	0.0162	CrCbGaD
Propericiazine—Diarrhoea—Capecitabine—breast cancer	0.00022	0.00035	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—breast cancer	0.000219	0.000347	CcSEcCtD
Propericiazine—Acepromazine—ALB—breast cancer	0.000217	0.0159	CrCbGaD
Propericiazine—Hyperhidrosis—Epirubicin—breast cancer	0.000217	0.000344	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—breast cancer	0.000217	0.000344	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—breast cancer	0.000214	0.000339	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—breast cancer	0.000213	0.000338	CcSEcCtD
Propericiazine—Thioproperazine—ALB—breast cancer	0.000213	0.0156	CrCbGaD
Propericiazine—Dry mouth—Doxorubicin—breast cancer	0.000212	0.000336	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—breast cancer	0.000212	0.000335	CcSEcCtD
Propericiazine—Rash—Docetaxel—breast cancer	0.00021	0.000333	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—breast cancer	0.00021	0.000333	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—breast cancer	0.00021	0.000332	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—breast cancer	0.000209	0.000332	CcSEcCtD
Propericiazine—Thiothixene—ALB—breast cancer	0.000209	0.0153	CrCbGaD
Propericiazine—Pipotiazine—ALB—breast cancer	0.000209	0.0153	CrCbGaD
Propericiazine—Thioridazine—CYP2D6—breast cancer	0.000208	0.0153	CrCbGaD
Propericiazine—Oedema—Doxorubicin—breast cancer	0.000208	0.000329	CcSEcCtD
Propericiazine—Infection—Doxorubicin—breast cancer	0.000206	0.000327	CcSEcCtD
Propericiazine—Vomiting—Capecitabine—breast cancer	0.000205	0.000325	CcSEcCtD
Propericiazine—Rash—Capecitabine—breast cancer	0.000203	0.000322	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—breast cancer	0.000203	0.000322	CcSEcCtD
Propericiazine—Dermatitis—Capecitabine—breast cancer	0.000203	0.000322	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—breast cancer	0.000203	0.000321	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—breast cancer	0.000201	0.000318	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—breast cancer	0.0002	0.000317	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—breast cancer	0.0002	0.000316	CcSEcCtD
Propericiazine—Methotrimeprazine—CYP2D6—breast cancer	0.000199	0.0146	CrCbGaD
Propericiazine—Nausea—Docetaxel—breast cancer	0.000198	0.000313	CcSEcCtD
Propericiazine—Promethazine—CYP2D6—breast cancer	0.000196	0.0143	CrCbGaD
Propericiazine—Hypotension—Doxorubicin—breast cancer	0.000194	0.000308	CcSEcCtD
Propericiazine—Constipation—Epirubicin—breast cancer	0.000192	0.000304	CcSEcCtD
Propericiazine—Nausea—Capecitabine—breast cancer	0.000191	0.000303	CcSEcCtD
Propericiazine—Perphenazine—CYP2D6—breast cancer	0.000191	0.014	CrCbGaD
Propericiazine—Body temperature increased—Methotrexate—breast cancer	0.00019	0.000301	CcSEcCtD
Propericiazine—Clomipramine—CYP3A4—breast cancer	0.000189	0.0139	CrCbGaD
Propericiazine—Insomnia—Doxorubicin—breast cancer	0.000188	0.000298	CcSEcCtD
Propericiazine—Quetiapine—CYP2D6—breast cancer	0.000187	0.0137	CrCbGaD
Propericiazine—Dyspnoea—Doxorubicin—breast cancer	0.000185	0.000294	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—breast cancer	0.000185	0.000293	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—breast cancer	0.000178	0.000282	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—breast cancer	0.000177	0.000281	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—breast cancer	0.000177	0.00028	CcSEcCtD
Propericiazine—Fluphenazine—ABCB1—breast cancer	0.000172	0.0126	CrCbGaD
Propericiazine—Hypersensitivity—Epirubicin—breast cancer	0.000165	0.000262	CcSEcCtD
Propericiazine—Clomipramine—ALB—breast cancer	0.000165	0.0121	CrCbGaD
Propericiazine—Body temperature increased—Doxorubicin—breast cancer	0.000164	0.00026	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—breast cancer	0.000164	0.00026	CcSEcCtD
Propericiazine—Perphenazine—CYP3A4—breast cancer	0.000164	0.012	CrCbGaD
Propericiazine—Quetiapine—CYP3A4—breast cancer	0.000161	0.0118	CrCbGaD
Propericiazine—Clomipramine—ABCB1—breast cancer	0.000158	0.0116	CrCbGaD
Propericiazine—Diarrhoea—Epirubicin—breast cancer	0.000154	0.000243	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—breast cancer	0.000153	0.000243	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—breast cancer	0.000153	0.000242	CcSEcCtD
Propericiazine—Chlorpromazine—CYP2D6—breast cancer	0.000152	0.0111	CrCbGaD
Propericiazine—Rash—Methotrexate—breast cancer	0.000151	0.00024	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—breast cancer	0.000151	0.00024	CcSEcCtD
Propericiazine—Promazine—CYP3A4—breast cancer	0.000148	0.0108	CrCbGaD
Propericiazine—Vomiting—Epirubicin—breast cancer	0.000143	0.000226	CcSEcCtD
Propericiazine—Nausea—Methotrexate—breast cancer	0.000142	0.000226	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—breast cancer	0.000142	0.000225	CcSEcCtD
Propericiazine—Rash—Epirubicin—breast cancer	0.000142	0.000224	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—breast cancer	0.000141	0.000224	CcSEcCtD
Propericiazine—Promethazine—ABCB1—breast cancer	0.00014	0.0102	CrCbGaD
Propericiazine—Trifluoperazine—ABCB1—breast cancer	0.000138	0.0101	CrCbGaD
Propericiazine—Quetiapine—ABCB1—breast cancer	0.000134	0.0098	CrCbGaD
Propericiazine—Nausea—Epirubicin—breast cancer	0.000133	0.000211	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—breast cancer	0.000132	0.000209	CcSEcCtD
Propericiazine—Rash—Doxorubicin—breast cancer	0.000131	0.000208	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—breast cancer	0.000131	0.000207	CcSEcCtD
Propericiazine—Chlorpromazine—CYP3A4—breast cancer	0.00013	0.00953	CrCbGaD
Propericiazine—Nausea—Doxorubicin—breast cancer	0.000123	0.000196	CcSEcCtD
Propericiazine—Chlorpromazine—ALB—breast cancer	0.000113	0.00831	CrCbGaD
Propericiazine—Chlorpromazine—ABCB1—breast cancer	0.000108	0.00793	CrCbGaD
Propericiazine—ADRA2A—Signaling Pathways—HSP90AA1—breast cancer	2.49e-05	0.000259	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HES1—breast cancer	2.47e-05	0.000258	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—breast cancer	2.47e-05	0.000257	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CD—breast cancer	2.47e-05	0.000257	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLA2G4A—breast cancer	2.46e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NCOR1—breast cancer	2.46e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TYMS—breast cancer	2.45e-05	0.000256	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CAV1—breast cancer	2.45e-05	0.000255	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—breast cancer	2.44e-05	0.000254	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF1—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CSF2—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NCOR1—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PLA2G4A—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—RAF1—breast cancer	2.42e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRL—breast cancer	2.42e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR1—breast cancer	2.42e-05	0.000252	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KDR—breast cancer	2.42e-05	0.000252	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NRG1—breast cancer	2.41e-05	0.000251	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—H2AFX—breast cancer	2.39e-05	0.00025	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2—breast cancer	2.39e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADAM10—breast cancer	2.38e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STK11—breast cancer	2.38e-05	0.000249	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—E2F1—breast cancer	2.38e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CB—breast cancer	2.37e-05	0.000247	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLG—breast cancer	2.36e-05	0.000246	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—breast cancer	2.36e-05	0.000246	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT2—breast cancer	2.33e-05	0.000243	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FN1—breast cancer	2.33e-05	0.000243	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—breast cancer	2.32e-05	0.000242	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF10—breast cancer	2.32e-05	0.000242	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKBIA—breast cancer	2.3e-05	0.00024	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A1—breast cancer	2.3e-05	0.00024	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SPP1—breast cancer	2.28e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ERCC2—breast cancer	2.28e-05	0.000238	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH1—breast cancer	2.28e-05	0.000237	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—breast cancer	2.27e-05	0.000237	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB3—breast cancer	2.26e-05	0.000236	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—KRAS—breast cancer	2.26e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGFR2—breast cancer	2.26e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CD—breast cancer	2.24e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFA—breast cancer	2.24e-05	0.000233	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APC—breast cancer	2.23e-05	0.000232	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—breast cancer	2.23e-05	0.000232	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KIT—breast cancer	2.23e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFBR2—breast cancer	2.21e-05	0.00023	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGF—breast cancer	2.2e-05	0.00023	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL2—breast cancer	2.17e-05	0.000227	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITPR1—breast cancer	2.17e-05	0.000226	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TERT—breast cancer	2.17e-05	0.000226	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT5A—breast cancer	2.16e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB4—breast cancer	2.16e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP3—breast cancer	2.16e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CB—breast cancer	2.15e-05	0.000224	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—breast cancer	2.14e-05	0.000223	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK3—breast cancer	2.13e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGFR1—breast cancer	2.1e-05	0.000219	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BRAF—breast cancer	2.09e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SMAD4—breast cancer	2.09e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1R—breast cancer	2.08e-05	0.000216	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—breast cancer	2.07e-05	0.000216	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—breast cancer	2.07e-05	0.000216	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—breast cancer	2.07e-05	0.000215	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—breast cancer	2.04e-05	0.000213	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HES1—breast cancer	2.04e-05	0.000213	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT2—breast cancer	2.04e-05	0.000212	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—breast cancer	2.03e-05	0.000212	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NCOR1—breast cancer	2.03e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLA2G4A—breast cancer	2.03e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—breast cancer	2.02e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—breast cancer	2.01e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CSF2—breast cancer	2.01e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF1—breast cancer	2.01e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CAV1—breast cancer	2e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—RAF1—breast cancer	2e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRG1—breast cancer	1.99e-05	0.000207	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KDR—breast cancer	1.98e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAV1—breast cancer	1.98e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—H2AFX—breast cancer	1.98e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2—breast cancer	1.98e-05	0.000206	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—E2F1—breast cancer	1.96e-05	0.000205	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CD—breast cancer	1.96e-05	0.000204	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CB—breast cancer	1.95e-05	0.000204	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—breast cancer	1.94e-05	0.000202	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—breast cancer	1.94e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—breast cancer	1.93e-05	0.000201	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HRAS—breast cancer	1.92e-05	0.0002	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—KRAS—breast cancer	1.92e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FN1—breast cancer	1.91e-05	0.000199	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SPP1—breast cancer	1.89e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKBIA—breast cancer	1.88e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—breast cancer	1.88e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH1—breast cancer	1.87e-05	0.000194	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB3—breast cancer	1.86e-05	0.000194	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGFR2—breast cancer	1.86e-05	0.000194	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—breast cancer	1.85e-05	0.000193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—breast cancer	1.82e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KIT—breast cancer	1.82e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APC—breast cancer	1.82e-05	0.00019	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGF—breast cancer	1.8e-05	0.000188	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—breast cancer	1.8e-05	0.000188	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2—breast cancer	1.79e-05	0.000187	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TERT—breast cancer	1.79e-05	0.000186	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—breast cancer	1.76e-05	0.000184	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MDM2—breast cancer	1.75e-05	0.000183	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAF1—breast cancer	1.75e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK3—breast cancer	1.75e-05	0.000182	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RELA—breast cancer	1.74e-05	0.000181	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGFR1—breast cancer	1.74e-05	0.000181	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB2—breast cancer	1.73e-05	0.00018	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BRAF—breast cancer	1.71e-05	0.000179	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—breast cancer	1.71e-05	0.000178	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MTOR—breast cancer	1.71e-05	0.000178	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CB—breast cancer	1.71e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—breast cancer	1.69e-05	0.000177	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—breast cancer	1.67e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT2—breast cancer	1.67e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—breast cancer	1.67e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—breast cancer	1.66e-05	0.000173	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CAV1—breast cancer	1.65e-05	0.000172	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—breast cancer	1.64e-05	0.000171	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KDR—breast cancer	1.63e-05	0.00017	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HRAS—breast cancer	1.63e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	1.6e-05	0.000167	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1B—breast cancer	1.6e-05	0.000167	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—breast cancer	1.59e-05	0.000166	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	1.59e-05	0.000166	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	1.59e-05	0.000165	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—breast cancer	1.58e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CD—breast cancer	1.58e-05	0.000165	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FN1—breast cancer	1.57e-05	0.000164	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—KRAS—breast cancer	1.57e-05	0.000164	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—breast cancer	1.57e-05	0.000164	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2—breast cancer	1.57e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—breast cancer	1.56e-05	0.000163	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—breast cancer	1.56e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	1.55e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	1.54e-05	0.000161	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—breast cancer	1.53e-05	0.000159	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JUN—breast cancer	1.53e-05	0.000159	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—breast cancer	1.51e-05	0.000158	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CTNNB1—breast cancer	1.51e-05	0.000158	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APC—breast cancer	1.51e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KIT—breast cancer	1.51e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	1.51e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—breast cancer	1.49e-05	0.000156	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGF—breast cancer	1.49e-05	0.000155	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—breast cancer	1.48e-05	0.000155	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1A—breast cancer	1.48e-05	0.000154	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTEN—breast cancer	1.48e-05	0.000154	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK8—breast cancer	1.44e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	1.44e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	1.44e-05	0.00015	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—breast cancer	1.44e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MDM2—breast cancer	1.44e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAF1—breast cancer	1.43e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RELA—breast cancer	1.43e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB2—breast cancer	1.42e-05	0.000148	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BRAF—breast cancer	1.42e-05	0.000148	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MTOR—breast cancer	1.4e-05	0.000146	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	1.4e-05	0.000146	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CB—breast cancer	1.38e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—breast cancer	1.38e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT2—breast cancer	1.38e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—breast cancer	1.37e-05	0.000143	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SRC—breast cancer	1.37e-05	0.000143	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—breast cancer	1.37e-05	0.000143	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.34e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.33e-05	0.000139	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—breast cancer	1.33e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.32e-05	0.000138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—breast cancer	1.32e-05	0.000138	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.31e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.31e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.31e-05	0.000136	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.3e-05	0.000135	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.3e-05	0.000135	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.29e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2—breast cancer	1.28e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.28e-05	0.000133	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK3—breast cancer	1.26e-05	0.000131	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.25e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.25e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JUN—breast cancer	1.25e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.24e-05	0.000129	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—breast cancer	1.23e-05	0.000128	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—breast cancer	1.22e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.22e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.21e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.21e-05	0.000126	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—breast cancer	1.2e-05	0.000125	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTEN—breast cancer	1.19e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.19e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.19e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.18e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.18e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.18e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.18e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.17e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.15e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.15e-05	0.00012	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KRAS—breast cancer	1.13e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.12e-05	0.000117	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.11e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.1e-05	0.000115	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.09e-05	0.000114	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.08e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.08e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.07e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.06e-05	0.000111	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.06e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.05e-05	0.00011	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—breast cancer	1.04e-05	0.000108	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.03e-05	0.000108	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.03e-05	0.000108	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.03e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.02e-05	0.000107	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—breast cancer	1.01e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—breast cancer	1e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1e-05	0.000104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	9.99e-06	0.000104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTEN—breast cancer	9.97e-06	0.000104	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—breast cancer	9.82e-06	0.000102	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	9.75e-06	0.000102	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	9.73e-06	0.000101	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HRAS—breast cancer	9.63e-06	0.0001	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KRAS—breast cancer	9.28e-06	9.67e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SRC—breast cancer	9.25e-06	9.64e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—breast cancer	9.21e-06	9.61e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	9e-06	9.39e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—breast cancer	8.92e-06	9.29e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	8.52e-06	8.88e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	8.52e-06	8.88e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—breast cancer	8.5e-06	8.86e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—breast cancer	8.41e-06	8.77e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—breast cancer	8.29e-06	8.64e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	8.27e-06	8.62e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—breast cancer	8.24e-06	8.59e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—breast cancer	8.1e-06	8.45e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HRAS—breast cancer	7.88e-06	8.22e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KRAS—breast cancer	7.66e-06	7.98e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—breast cancer	7.55e-06	7.87e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	7.03e-06	7.33e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—breast cancer	6.96e-06	7.26e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—breast cancer	6.87e-06	7.16e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—breast cancer	6.8e-06	7.09e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HRAS—breast cancer	6.51e-06	6.78e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—breast cancer	6.23e-06	6.49e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—breast cancer	5.75e-06	5.99e-05	CbGpPWpGaD
